3.5. FH Patients Have Decreased PON1 Activity, Increased MDA-apoAI Adducts, Defective HDL Cholesterol Efflux Capacity and Impaired HDL Anti-Inflammatory Function. The gene discussed is APOA1; the disease is familial hyperaldosteronism.